Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA approves Boca Glycopyrrolate Tablet ANDA
Glycopyrrolate tablets are used as adjunctive therapy to treat peptic ulcers. Glycopyrrolate Tablets USP, 1 mg and 2 mg are generic equivalent to Robinul Tablets, 1 mg and
Glycopyrrolate tablets are used as adjunctive therapy to treat peptic ulcers. Glycopyrrolate Tablets USP, 1 mg and 2 mg are generic equivalent to Robinul Tablets, 1 mg and
One trial was conducted in type 1 diabetes patients and the other in type 2 patients, both of which compared two ultrafast insulin analog products formulated with rHuPH20
Androderm,a once daily skin patch, called a transdermal delivery system, is a testosterone replacement therapy in males with a deficiency or absence of endogenous testosterone. It delivers consistent,
Euflexxa is a bioengineered, non-avian product which provides relief from osteoarthritis knee pain, especially when simple pain medications such as acetaminophen or from exercise and physical therapy do
Dynavax expects to receive nearly $200m in milestone payments over the term of the alliance. Dynavax and GSK will focus on the development of a TLR8 inhibitor to
XmAb5871, a humanized monoclonal antibody using selective dual-targeting mechanism for B cell inhibition by targeting the antigen CD19 and co-engaging CD32b (Fc?RIIb), helps in suppression of autoimmune response.
DEFINE (Determination of the Efficacy and safety of oral Fumarate IN rElapsing-remitting MS) a global, randomized, double-blind, placebo-controlled, dose-comparison trial enrolled 1,237 patients between 18 and 55 years
ImmuPharma and Cephalon had signed an option agreement in 2008,when the ImmuPharma designed and funded Phase IIb study was ongoing. ImmuPharma was paid $15m by Cephalon before the
Newron will now re-assess all the opportunities for safinamide including re-partnering the compound at some stage. Newron can also pursue marketing of this new chemical entity for Parkinson’s
Modernizing Medicine EMA-Ophthalmology HER featuring a bi-directional communication interface enables a seamless workflow experience across both clinical and financial areas of ophthalmology practice, besides enabling access from anywhere